3463 results for «2023年+俄乌冲突+全球能源安全+经济影响»
3463 results
Beyond TAVI
16 Nov 2025 – From PCR London Valves 2025
This session offers a glimpse into cutting-edge structural heart interventions beyond TAVI. It introduces novel devices in early development stages targeting aortic valve stenosis and leaflet modification, discusses strategies to facilitate or defer TAVI, and provides opportunities for engagement with early-stage start-up partners innovating in structural...
Planning a lifetime of care in younger patients with Evolut FX+: from index valve to future options
17 Nov 2025 – From PCR London Valves 2025
Watch this PCR London Valves 2025 session to take a deep look at the latest evidence in low-risk aortic stenosis, the durability of contemporary valves, and how anatomy — especially in women and patients with small annuli — shapes long-term strategy.
From index TAVI with Evolut FX+...
Featured research: latest advances in mitral TEER and valve repair technologies
16 Nov 2025 – From PCR London Valves 2025
This session presents featured research on mitral valve interventions, including two-year outcomes from the MitraClip G4 EXPAND study, comparative data of mitral TEER versus redo surgery in failed surgical repair, evidence from novel TEER programs in non-surgical centers, and safety and efficacy results of the NeoNova...
Shaping the treatment of mitral regurgitation with the Intrepid transcatheter mitral valve replacement (TMVR) system
17 Nov 2025 – From PCR London Valves 2025
This session presents an in-depth examination of the Intrepid transcatheter mitral valve replacement (TMVR) system, focusing on its role in treating mitral regurgitation. It covers the system's design features, ongoing clinical research, and long-term durability, complemented by detailed analyses of transapical 5-year outcomes and current trial...
Featured research: advances in TAVI for aortic regurgitation and severe stenosis
16 Nov 2025 – From PCR London Valves 2025
This session delivers an in-depth analysis of innovative research in transcatheter aortic valve implantation (TAVI). It includes pivotal studies such as the LANDMARK trial subanalysis on cardiac damage in severe aortic stenosis patients, long-term efficacy comparisons of balloon- and self-expanding valves, and evaluations of valve performance...
TAVI in 2025: transforming care with the new valvular heart disease guidelines
18 Nov 2025 – From PCR London Valves 2025
This session explores how the 2025 valvular heart disease guidelines are transforming the landscape of TAVI care and clinical decision-making. It highlights the paradigm shift in managing severe aortic stenosis and provides a global perspective on the challenges and strategies for managing an expanding TAVI patient...
TAVI: high coronary risk
16 Nov 2025 – From PCR London Valves 2025
This session addresses the complexities and innovative approaches to managing high coronary risk during TAVI procedures. It features advanced techniques such as the double chimney-stent method, valve-in-valve strategies to prevent coronary obstruction, and challenging cases involving TAVI-in-TAVI. These insights provide practical guidance for interventionalists navigating high-risk...
The index valve matters: optimal index TAVI for a lifetime of possibilities
18 Nov 2025 – From PCR London Valves 2025
Discover how thoughtful index valve selection and implantation techniques can shape the long-term management of patients undergoing TAVI. This PCR London Valves 2025 session highlights treatment considerations for low- and intermediate-risk patients, explores how valve choice affects the feasibility of future interventions, and examines strategies to...
TAVI: nightmare in the cathlab - Cardiac arrest, aortic root rupture & duct occluder
16 Nov 2025 – From PCR London Valves 2025
Explore critical complications encountered during TAVI procedures in this session, which highlights urgent scenarios such as cardiac arrest from calcific leaflet shift, aortic root rupture, and embolisation events. It also covers salvage techniques like TAVR-in-TAVR-in-SAVR in cardiogenic shock and management of acute left main occlusion with...
The next frontier in LAA closure: innovations and opportunities
17 Nov 2025 – From PCR London Valves 2025
Explore the forefront of left atrial appendage (LAA) closure with this session focusing on the latest innovations and clinical opportunities. Topics include recent data on WATCHMAN FLX PRO and VersaCross Connect systems, workflow strategies to improve procedural efficiency, and discussions on upcoming clinical trials such as...
Challenging mitral TEER: overcoming access limitations and anatomical challenges
16 Nov 2025 – From PCR London Valves 2025
This session delves into the challenges of mitral transcatheter edge-to-edge repair (TEER), focusing on complex cases such as denied access, patch dehiscence-induced regurgitation, and functional mitral regurgitation due to amyloid cardiomyopathy. It also highlights innovative imaging approaches, including the use of transthoracic echocardiography as a rescue...
Challenging tricuspid TEER
16 Nov 2025 – From PCR London Valves 2025
This session focuses on the intricacies of transcatheter tricuspid edge-to-edge repair (TEER) addressing iatrogenic tricuspid regurgitation, failed surgical valve repair, and approaches for patients unsuitable for valve replacement. It also examines the management of multiple clip detachments and the procedural nuances required to navigate complex tricuspid...
Complex combined interventions
16 Nov 2025 – From PCR London Valves 2025
This session presents complex combined interventions tackling multiple valvular and structural heart challenges simultaneously. It highlights innovative procedural approaches such as the 'super combo' techniques, strategies for managing deteriorative mitral regurgitation post-tricuspid valve replacement, and comprehensive management of torrential tricuspid regurgitation within rheumatic multivalvular disease contexts,...
Retrieval of embolised devices
16 Nov 2025 – From PCR London Valves 2025
This session delves into the complex scenarios of embolised device retrieval, exploring various interventions such as management of Lambre device embolisation, alternatives to surgery for superior vena cava baffle stent embolisation, novel strategies for chronically embolised Gore Helex atrial septal occluder device retrieval, and challenging redo...
Cutting-edge research in transcatheter tricuspid valve therapies
16 Nov 2025 – From PCR London Valves 2025
This session highlights cutting-edge research on tricuspid valve interventions, including the impact of inflow gradients on outcomes, global registry data on bicaval valve therapy, patient selection algorithms, and prognostic score validations for severe tricuspid regurgitation.
Late-breaking evidence in structural and coronary interventions - Part 2
16 Nov 2025 – From PCR London Valves 2025
This session presents the latest data from pivotal late-breaking trials in interventional cardiology. Highlights include one-year results from the ADALA trial, first-in-man use of the Vivasure PerQseal Elite for large hole arterial closure, two-year outcomes of the DragonFly system in China, six-month European outcomes, and insights...
TAVI in bicuspid anatomy
16 Nov 2025 – From PCR London Valves 2025
Explore the complexities of performing TAVI in bicuspid aortic valve anatomies, with expert discussions on BASILICA tricuspidisation, procedural planning for extreme calcification, valve sizing, and challenges associated with type 0 bicuspid valves and severe calcification.
AICT-AsiaPCR 2025 Awards ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Awards ceremony celebrates outstanding achievements and innovations in the field of interventional cardiology. This event recognizes the contributions of clinicians and researchers who have advanced cardiovascular care and highlights excellence across various domains within the specialty.
AICT-AsiaPCR 2025 Closing ceremony
11 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Closing ceremony marks the culmination of a comprehensive Course, reflecting on key scientific advancements, collaborative achievements, and the shared commitment to advancing cardiovascular medicine and patient care.
AICT-AsiaPCR 2025 Opening ceremony
10 Oct 2025 – From AICT-AsiaPCR 2025
The AICT-AsiaPCR 2025 Opening Ceremony marked the commencement of the conference's comprehensive program, setting the stage for cutting-edge discussions and advancements in interventional cardiology across the Asia-Pacific region.